Aventis and Peptor Limited Sign Agreement for the License, Development and Commercialisation of New Diabetes Therapy
30-Jul-2002 -
Strasbourg, France -Aventis and Peptor
Limited, a biopharmaceutical company
based in Rehovat, Israel, and in Erkrath,
Germany, have signed an exclusive
worldwide license, development and
commercialisation agreement for a new
diabetes therapy. The new drug, called
DiaPep277TM, is being ...
Aventis
blindness
blood tests
+15